Press Releases
KARO BIO ANNUAL GENERAL MEETING
Friday, April 25, 2008
POSITIVE RESULTS IN FIRST CLINICAL STUDY WITH ANTI DIABETES COMPOUND KB3305
Thursday, April 17, 2008
Events / Presentations
BioEquity Europé 2008, Amsterdam
Wednesday, May 28, 2008
Financial Reports
INTERIM REPORT JANUARY–MARCH 2008
Thursday, April 24, 2008
Annual Report 2007
Monday, April 07, 2008
Share price
5/16/2008 6:01 PM
-4.24% 5.65 SEK, Vol: 613400
Search
Business Model
Generate new innovative projects through drug discovery targeting nuclear receptors
Reduce risk by maintaining a focused project portfolio and building a clinical pipeline
Bring selected projects in niche areas to the market or late stage out licensing
License out compounds intended for treatment of broad patient populations
Read more »
Karo Bio Pipeline
Read more »